Phenylbutazone and Leukaemia

1965; Wiley; Volume: 178; Issue: 4 Linguagem: Inglês

10.1111/j.0954-6820.1965.tb04295.x

ISSN

0001-6101

Autores

Mogens Krogh Jensen, Kai Roll,

Tópico(s)

Cancer Treatment and Pharmacology

Resumo

Acta Medica ScandinavicaVolume 178, Issue 4 p. 505-513 Phenylbutazone and Leukaemia Mogens Krogh Jensen, Mogens Krogh Jensen the Medical Department A (Head: K. Brøchner-Mortensen, M. D.), Rigshospitalet, Copenhagen, DenmarkSearch for more papers by this authorKai Roll, Kai Roll the Medical Department A (Head: K. Brøchner-Mortensen, M. D.), Rigshospitalet, Copenhagen, DenmarkSearch for more papers by this author Mogens Krogh Jensen, Mogens Krogh Jensen the Medical Department A (Head: K. Brøchner-Mortensen, M. D.), Rigshospitalet, Copenhagen, DenmarkSearch for more papers by this authorKai Roll, Kai Roll the Medical Department A (Head: K. Brøchner-Mortensen, M. D.), Rigshospitalet, Copenhagen, DenmarkSearch for more papers by this author First published: January/December 1965 https://doi.org/10.1111/j.0954-6820.1965.tb04295.xCitations: 16AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume178, Issue4January/December 1965Pages 505-513 RelatedInformation

Referência(s)